CMS, FDA Face Weakened Authority Following SCOTUS’ Chevron Decision

By Jessica Karins, Sigi Ris / June 28, 2024 at 1:41 PM

Substantially weakening the power of federal agencies, the Supreme Court Friday (June 28) overruled the longstanding Chevron deference precedent that has required courts defer to federal agencies’ reasonable interpretations of statute, in its most consequential case of the term on the future of federal health policy.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.